ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 1,346.00
+3.00 (0.22%)
At close: Nov 6, 2026
ADBiotech Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 12,569 | 12,897 | 11,136 | 10,472 | 10,632 | 11,840 |
Revenue Growth | -0.82% | 15.81% | 6.34% | -1.50% | -10.21% | 20.63% |
Gross Profit Gross Profit Growth | 5,011 | 5,148 | 4,007 | 3,218 | 3,111 | 5,009 |
Operating Income Operating Income Growth | -4,410 | -3,501 | -4,117 | -4,772 | -4,984 | -1,555 |
Net Income Net Income Growth | -3,528 | -3,304 | -7,952 | -2,863 | 2,696 | -2,664 |
Earnings Per Share EPS Growth | -207.77 | -275.09 | -870.00 | -313.27 | 118.54 | -347.00 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Biotechnology Sector Biotechnology Sector Growth | 11,105 | 11,575 | 10,463 | 8,599 | 10,632 |
Online Platform Sector Online Platform Sector Growth | 1,339 | 1,319 | 673.29 | 1,875 | - |
Parking Lot Operations Division Parking Lot Operations Division Growth | - | 3.43 | - | - | - |
Total Total Growth | 12,569 | 12,897 | 11,136 | 10,472 | 10,632 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 15,648 | 11,470 | 1,679 | 9,414 | 8,628 | 2,781 |
Total Debt Total Debt Growth | 14,880 | 16,802 | 11,972 | 13,610 | 12,771 | 13,168 |
Net Cash (Debt) Net Cash Growth | 767.95 | -5,332 | -10,292 | -4,196 | -4,143 | -10,388 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 45.22 | -443.97 | -1126.02 | -459.08 | -410.96 | -1351.57 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -860.98 | -1,319 | -4,092 | 314.93 | -8,592 | -2,186 |
Capital Expenditures CapEx Growth | -15,812 | -15,811 | -193.38 | -239.9 | -726.72 | -3,561 |
Free Cash Flow Free Cash Flow Growth | -16,673 | -17,130 | -4,285 | 75.03 | -9,319 | -5,747 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.87% | 39.91% | 35.98% | 30.73% | 29.26% | 42.31% |
Operating Margin | -35.09% | -27.15% | -36.97% | -45.57% | -46.88% | -13.13% |
Pretax Margin | -28.25% | -27.20% | -80.93% | -52.11% | 25.36% | -20.39% |
Profit Margin | -28.07% | -25.62% | -71.41% | -27.34% | 25.36% | -22.50% |
FCF Margin | -132.65% | -132.82% | -38.48% | 0.72% | -87.66% | -48.54% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 11.39 | - |
P/FCF Ratio | - | - | - | 398.99 | - | - |
PS Ratio | 2.88 | 2.58 | 1.71 | 2.86 | 2.89 | 3.81 |